Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
-
BPGbio Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence
-
REKOR SYSTEMS EXPECTS Q3 2025 RECORD REVENUE, A SIGNIFICANT IMPROVEMENT IN ADJUSTED EBITDA AND GROSS MARGIN
-
OTC Markets Group Welcomes Aspira Women's Health Inc. to OTCQX
-
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplan
-
Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
-
TradePending Joins the Mazda Digital Certified Program
-
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
-
Inception Growth Acquisition Limited Announces Extension of Business Combination Period
-
AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network’s Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
-
SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics
-
Iantrek Announces Commercial Launch of AlloFlo™ Uveo, the Only Surgical Treatment Targeting the Uveoscleral Pathway in Glaucoma
-
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
-
Assembly Biosciences Announces Upcoming Investor Conference Participation
-
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
-
Aduro Clean Technologies to Participate in the 51st Annual New Orleans Investment Conference
-
The Future of Marketing To Take Center Stage at OAAA’s 2026 OOH Media Conference
-
Bitfarms Announces the Retirement of Jeff Lucas, Chief Financial Officer, and the Appointment of Jonathan Mir as Successor
-
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
-
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
-
REKOR SYSTEMS EXPECTS Q3 2025 RECORD REVENUE, A SIGNIFICANT IMPROVEMENT IN ADJUSTED EBITDA AND GROSS MARGIN
-
Talen Energy to Report Third Quarter 2025 Financial Results on November 5, 2025
-
Frontier Medicines Announces Third Precision Oncology Development Candidate
-
OTC Markets Group Welcomes Aspira Women's Health Inc. to OTCQX
-
ESGold Reports Positive Results from Colombian Tailings
-
CECO Environmental to Release Third Quarter Earnings and Host Conference Call on October 28
-
Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025
-
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
-
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
-
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
Meet The Winners of the 2025 'MADE in NJ' Manufacturing Day Awards
-
YieldMax® ETFs Announces Weekly Distributions on ULTY, LFGY, YMAX, YMAG, SLTY, and Others
-
Castellum, Inc.’s Subsidiary Specialty Systems, Inc. Adds IT Services for GSA MAS Contract
-
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
-
K92 Mining Announces 2025 Third Quarter Financial Results Conference Call Details
-
Cespira Signs Agreement to Supply Components for a Customer Truck Trial
-
Clearway Energy, Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Nova Minerals Engaged Ahead of High-Level Critical Minerals Talks with U.S. President Donald Trump
-
Record Number of Participants Deployed Kraken Robotics’ Synthetic Aperture Sonar at REPMUS 2025
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
-
Form 8.5 (EPT/RI) - Epwin Group Plc
-
Toobit Launches 100% Compensation Event for Losses Incurred in October
-
Wrap Achieves Key Milestone in Counter-UAS Development with Successful MERLIN Stage One Testing Conducted by Wrap
-
Elite Express Holding Inc. Announces Third Quarter 2025 Results
-
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
-
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
-
Cenovus Energy acquires 8.5% of MEG Energy common shares
-
Unity Bancorp Reports Quarterly Earnings of $14.4 Million
